|
|
|
| Influence of Thymopeptide Enteric Injection adjuvant chemotherapy on CD3+,CD4+,NK cell level in patients with ovarian cancer |
| WEI Shu-qing1 SHI Yu-xia2▲ |
1.Department of Internal Medicine-Oncology,Shanxi Tumor Hospital,Taiyuan 030013,China;
2.Department of Orthopaedics,Shanxi Tumor Hospital,Taiyuan 030013,China |
|
|
|
|
Abstract ObjectiveTo study the influence of Thymopeptide Enteric Injection adjuvant chemotherapy on CD3+,CD4+, NK cell level in patients with ovarian cancer.MethodsFrom July 2013 to August 2016,98 patients with ovarian carcinoma treated in our hospital were studied,and they were divided into observation group and control group by using digital method,and there were 49 cases in each group.The patients in the observation group were given Thymopeptide Enteric Injection adjuvant chemotherapy,while the control group was given chemotherapy.CD3+,CD4+,NK cell level and so on between two groups were compared.ResultsAfter treatment,the excellent and good rate of the observation group was 95.92%,which was significantly higher than that of the control group(79.59%),and the difference was statistically significant(P＜0.05).After treatment,the level of CD3+,CD4+,and NK in the observation group were significantly higher than those in the control group,the difference was statistically significant(P＜0.01).Compared with before treatment,he white blood cell count,neutrophil count and the number of hemoglobin decreased in the two groups,and the improvement degree of WBC count and neutrophil count in the observation group was significantly better than that in the control group,the difference was statistically significant(P＜0.01).ConclusionThymopeptide Enteric Injection adjuvant chemotherapy treating patients with ovarian cancer can improve effectively CD3+,CD4+,and NK cell level,regulate the peripheral hemogram of the patients,improve the therapeutic effect.
|
|
|
|
|
|
| [1] |
傅发展，吕笑俏，柳俊瑾，等.匹多莫德和脾氨肽对呼吸道反复感染儿童外周血T细胞亚群及其细胞因子的影响[J].中华医院感染学杂志，2017，27（1）：201-204.
|
| [2] |
丁媛，张宇，王艳平，等.STAT3基因功能获得性突变致免疫失调性疾病临床及免疫学特征研究[J].中华儿科杂志，2017，55（1）：30-36.
|
| [3] |
郭峰，张梅洁，许彦枝，等.自拟化湿行瘀清热方辅治口腔扁平苔藓疗效及对血清中结合珠蛋白浓度、T淋巴细胞亚群的影响[J].疑难病杂志，2017，16（1）：68-71.
|
| [4] |
刘翔.中西医结合治疗对亚急性肝衰竭人工肝支持术后T淋巴细胞和血氨的影响[J].陕西中医，2017，38（1）：39-40.
|
| [5] |
张颖，王蕾，庞楠楠，等.ITP小鼠外周血CD4+T细胞PD-1表达及血清 IFN-γ、IL-10水平观察[J].山东医药，2017，57（2）：35-36.
|
| [6] |
王琳，李洪伟，施裕新，等.高效抗逆转录病毒治疗联合化疗对HIV感染合并肺癌患者的CD4+计数和生存质量评分的影响[J].临床肺科杂志，2017，22（2）：220-222.
|
| [7] |
程越.胸腺肽注射液辅助化疗对卵巢癌患者免疫功能及生命质量的影响[J].肿瘤研究与临床，2016，28（1）：48-51.
|
| [8] |
陈诚，游雪云，付子毅，等.miR-26b在卵巢癌组织中的表达与功能[J].中国老年学杂志，2017，37（1）：15-17.
|
| [9] |
Migueles SA，Connors M.Long-term nonprogressive disease among untreated HIV-infected individuals：clinical implications of understanding immune control of HIV[J].JAMA，2011，304（2）：194-201.
|
| [10] |
Kiesel P，Beck M，Johnson N.Monitoring CD4 in whole blood with an opto-fluidic detector based on spatially modulated fluorescence emission[J].Cytometry A，2011，79（4）：317-324.
|
| [11] |
Ji YI，Lee BY，Kang YJ，et al.Expression patterns of Thymosin β4and cancer stem cell marker CD133 in ovarian cancers[J].Pathol Oncol Res，2013，19（2）：237-245.
|
| [12] |
Kim YC，Kim BG，Lee JH，et al.Thymosin β10expression driven by the human TERT promoter induces ovarian cancerspecific apoptosis through ROS production[J].PLoS One，2012，7（5）：35399-35400.
|
| [13] |
Rho SB，Chun T，Lee SH，et al.The interaction between E-tropomodulin and thymosin beta-10 rescues tumor cells from thymosin beta-10 mediated apoptosis by restoring actin architecture[J].FEBS Lett，2004，557（1）：57-63.
|
| [14] |
Lee SH，Zhang W，Choi JJ，et al.Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis[J].Oncogene，2001，20（46）：6700-6706.
|
| [15] |
Kondakova IV，Iunusova NV，Spirina LV，et al.Association of intracellular proteinase activities with the content of locomotor proteins in tissues of primary tumors and metastasis in ovarian cancer[J].Bioorg Khim，2014，40（6）：735-742.
|
|
|
|
